期刊
DIABETES
卷 58, 期 6, 页码 1275-1282出版社
AMER DIABETES ASSOC
DOI: 10.2337/db08-1001
关键词
-
资金
- NICHD NIH HHS [U54 HD012303, P50 HD012303] Funding Source: Medline
- NIDDK NIH HHS [DK075479, K08 DK075479] Funding Source: Medline
OBJECTIVE-Forkhead box O (FoxO) transcription factors represent evolutionarily conserved targets of insulin signaling regulating metabolism and cellular differentiation in response to changes in nutrient availability. Although the FoxO1 isoform is known to play a key role in adipogenesis, its physiological role ill differentiated adipose tissue remains unclear. RESEARCH DESIGN AND METHODS-In this study, we analyzed the phenotype of FoxO1. haploinsufficient mice to investigate the role of FoxO1 in high-fat, diet-induced obesity and adipose tissue metabolism. RESULTS-We showed that reduced FoxO1 expression protects mice against, obesity-related insulin resistance with marked improvement not, only in hepatic insulin sensitivity but, also in skeletal muscle insulin action. FoxO1 haploinsufficiency also resulted in increased peroxisome proliferator-activated receptor (PPAR)gamma gene expression in adipose tissue, with enhanced expression of PPAR gamma target, genes known to influence metabolism Moreover, treatment of mice with the PPAR gamma agonist, rosiglitazone caused a greater improvement in in vivo insulin sensitivity in FoxO1 haploinsufficient animals, including reductions in circulating proinflammatory cytokines. CONCLUSIONS-These findings indicate that FoxO1 proteins negatively regulate insulin action and that their effect may be explained, at least in part, by inhibition of PPAR gamma function. Diabetes 58:1275-1282, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据